Therapeutic Potential of Combining IL-6 and TNF Blockade in a Mouse Model of Allergic Asthma

Combined anti-cytokine therapy is a promising therapeutic approach for uncontrolled steroid-resistant asthma. In this regard, simultaneous blockade of IL-4 and IL-13 signaling by Dupilumab (anti-IL-4Ra monoclonal antibody) was recently approved for severe eosinophilic asthma. However, no therapeutic...

Descripción completa

Detalles Bibliográficos
Autores principales: Namakanova, Olga A., Gorshkova, Ekaterina A., Zvartsev, Ruslan V., Nedospasov, Sergei A., Drutskaya, Marina S., Gubernatorova, Ekaterina O.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8998171/
https://www.ncbi.nlm.nih.gov/pubmed/35408882
http://dx.doi.org/10.3390/ijms23073521

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8998171/
https://www.ncbi.nlm.nih.gov/pubmed/35408882
http://dx.doi.org/10.3390/ijms23073521

Ejemplares similares